Robert W. Wysocki

Robert W. Wysocki

Auto-generated profile, based on publicly available information

Robert W. Wysocki

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JPJuwon Park
Juwon Park
RWRobert W. Wysocki
Robert W. Wysocki
ZAZohreh Amoozgar
Zohreh Amoozgar
LMLaura Maiorino
Laura Maiorino
MFMiriam R. Fein
Miriam R. Fein
MEMikala Egeblad
Mikala Egeblad
Treatment with DNase I–coated nanoparticles prevents metastasis by targeting neutrophil extracellular traps induced by cancer cells in a mouse model.

1 November 2012 in Cell
Verified
Journal Article
Closed access
ZKZachary A. Knight
Zachary A. Knight
KTKeith Tan
Keith Tan
KBKivanc Birsoy
Kivanc Birsoy
SSSarah Schmidt
Sarah Schmidt
JGJennifer L. Garrison
Jennifer L. Garrison
JFJeffrey M. Friedman
Jeffrey M. Friedman

1 January 2010 in Cell Metabolism
Verified
Journal Article
Closed access
KHKristina Hedbacker
Kristina Hedbacker
KBKıvanç Birsoy
Kıvanç Birsoy
RWRobert W. Wysocki
Robert W. Wysocki
EAEsra Asilmaz
Esra Asilmaz
RARexford S. Ahima
Rexford S. Ahima
JFJeffrey M. Friedman
Jeffrey M. Friedman

1 February 2011 in Cell Metabolism
Verified
Journal Article
Closed access
CPCristian A. Pérez
Cristian A. Pérez
SSSarah A. Stanley
Sarah A. Stanley
RWRobert W. Wysocki
Robert W. Wysocki
JHJana Havranova
Jana Havranova
RARebecca Ahrens-Nicklas
Rebecca Ahrens-Nicklas
JFJeffrey M. Friedman
Jeffrey M. Friedman

30 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAlan de Brito Carneiro
Alan de Brito Carneiro
RWRobert W. Wysocki
Robert W. Wysocki
XZXu Zhang
Xu Zhang
VGVictor R. Gordeuk
Victor R. Gordeuk
RMRoberto F Machado
Roberto F Machado
Sickle cell disease (SCD) is characterized by chronic and episodic hemolysis, inducing endothelial cell dysfunction and death. Lipid droplets (LDs) accumulate intracellularly in response to stress but the role of LDs in hemin-stressed pulmonary microvascular cells remain unexplored. We hypothesized that LD formation is an adaptive response that improves endothelial cell survival during hemin-induced stress. We utilized cultures of human lung microvascular endothelial cells (hLMVECs) to test this hypothesis. Hemin alone was able to induce LD biogenesis in culture. In response to hemin treatment, we found an increase in cellular death by lactate dehydrogenase (LDH) assay when LD biogenesis was inhibited with a small molecule inhibitor of diacylglycerol acyltransferase 1 (DGAT1), A922500. Induction of LDs by treatment with oleic acid (OA) coupled with hemin resulted in improved endothelial cell survival. Hemin treatment was able to activate p-JNK and p-P38 signaling, while treatment with OA alone could not induce either signaling pathway. Hemin treatment combined with DGAT1 inhibition resulted in an increase in endothelial cell secreted IL-6 and IL-8 levels as measured by enzyme linked immunosorbent assay (ELISA), demonstrating an increase in endothelial cell dysfunction and stress. Induction of LD formation with oleic acid (OA) treatment resulted a reduction in secreted IL-6 and IL-8. Mitochondrial reactive oxygen species (ROS) production was decreased by OA treatment, as evidenced by MitoSOXRed assay. These data suggest that hLMVECs are protected from hemin-induced inflammation and death by the presence of LDs. Further studies are needed to explore the Hemin-LD-Cell Death axis for translational therapeutic use.